• Mashup Score: 0

    On this episode of Managed Care Cast, Ryan Haumschild, PharmD, MS, MBA, from Emory Healthcare and the Winship Cancer Institute, explains the evolution of biosimilar pharmacoeconomics and the different strategies that health care institutions can implement to reap the benefits of biosimilar savings.

    Tweet Tweets with this article
    • ICYMI: On the latest episode of #ManagedCareCast, @Rxhaums (@emoryhealthcare, @WinshipAtEmory) explains the evolution of #biosimilar pharmacoeconomics & different strategies #healthcare institutions can implement to reap benefits of biosimilar savings. https://t.co/mVT3tGyGwy https://t.co/a63IVz5ZV8

  • Mashup Score: 0

    On this episode of Managed Care Cast, we speak with the author of an article in the August issue of The American Journal of Managed CareĀ® about the premium tax credits for health insurance purchased through the health care marketplace, which were recently extended for another 2 years with the signing of the Inflation Reduction Act.

    Tweet Tweets with this article
    • On this episode of #ManagedCareCast, we speak with the author of an article in our August issue about premium tax credits for health insurance purchased through the #healthcare marketplace, which were recently extended under the Inflation Reduction Act. https://t.co/rzvDvXqosD https://t.co/Ggm4fh8cWV

  • Mashup Score: 1

    How much would have Medicare saved if it had the same ability to purchase generic drugs at the same price as individuals using direct-to-consumer (DTC) pharmacies like the Mark Cuban Cost Plus Drug Company? Billions, as it turns out.

    Tweet Tweets with this article
    • Have you listened to this week's #ManagedCareCast? šŸŽ§ We spoke with @DrHussainL, coauthor of an analysis that found #Medicare could have saved up to $3.6 billion in 2020 if it bought 77 generic drugs at @costplusdrugs 2022 prices. Listen here! https://t.co/5Zc81kFjIX https://t.co/iUDfHFzIiX

  • Mashup Score: 0

    This episode of Managed Care Cast features interviews with experts who discuss how the same efforts to stamp out COVID-19 also reduced Clostridioides difficile and the prospects for such mitigation efforts to continue.

    Tweet Tweets with this article
    • Have you listened to the latest episode of #ManagedCareCast? On this episode, experts discuss how the same efforts to stamp out #COVID19 also reduced Clostridium difficile. They expand on the prospects for such mitigation efforts to continueā€“Listen here! https://t.co/W7M0DHdzPX https://t.co/6UrZciC19p

  • Mashup Score: 2

    On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.

    Tweet Tweets with this article
    • Have you listened to the latest #ManagedCareCast? On this week's podcast, we speak with Laura Gladson (@NYUMarron), on the latest findings of the Health of the Air report, which was presented at #ATS2021. #AJMC https://t.co/OURp4BN6rM https://t.co/AOx1ZiWj1D

  • Mashup Score: 0

    An author of a study in the May 2021 issue of The American Journal of Managed CareĀ® describes how the COVID-19 pandemic, the aging of America, and already-existing workforce shortages will further threaten the dual-eligible population unless policy makers reform scope-of-practice laws.

    Tweet Tweets with this article
    • What Can Be Done to Ensure Access to Care for Dual-Eligible Beneficiaries? Listen to our latest #ManagedCareCast as we speak with an author of a study in the May 2021 issue of @AJMC_Journal. #AJMC25 https://t.co/EXi0YU9unG https://t.co/LTRxcUUjgX